Screener
Ocular Therapeutix OCUL Business Segments — Interest Expense Nonoperating
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Loss from operations | (93,340) | (63,917) |
| Other income (expense): | ||
| Interest income | 6,050 | 3,826 |
| Interest expense | (2,777) | (2,984) |
| Change in fair value of derivative liabilities | 1,455 | (978) |
| Total other income (expense), net | 4,728 | (136) |
| Net loss | $(88,612) | $(64,053) |
| Net loss per share, basic | $(0.40) | $(0.38) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's business segments — interest expense nonoperating?
- Ocular Therapeutix (OCUL) reported business segments — interest expense nonoperating of $2.78M in Q1 2026.
- How has Ocular Therapeutix's business segments — interest expense nonoperating changed year-over-year?
- Ocular Therapeutix's business segments — interest expense nonoperating decreased by 6.9% year-over-year, from $2.98M to $2.78M.
- What is the long-term trend for Ocular Therapeutix's business segments — interest expense nonoperating?
- Over 3 years (2022 to 2025), Ocular Therapeutix's business segments — interest expense nonoperating has grown at a 145.7% compound annual growth rate (CAGR), from -$798K to $11.83M.
- What does business segments — interest expense nonoperating mean?
- This metric captures the costs incurred on debt obligations and other financing arrangements that are not directly tied to core operational activities. It reflects the company's cost of capital and its reliance on external debt financing to fund research and development or commercialization efforts. High levels of interest expense can indicate significant financial leverage and potential liquidity risk.
Ask your AI about Ocular Therapeutix's business segments — interest expense nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude